Gut microbiota and intestinal lumen environment

The gut microbiota and intestinal lumen environment represent a complex, dynamic ecosystem comprising trillions of microorganisms, including bacteria, fungi, viruses, and archaea, that reside within the human gastrointestinal tract (NIH, 2023). This biological system performs essential functions such as the fermentation of non-digestible dietary fibers into short-chain fatty acids, the synthesis of vitamins K and B12, and the regulation of the host's innate and adaptive immune systems (Nature Reviews Microbiology, 2022). Dysbiosis, characterized by a loss of microbial diversity or an overgrowth of pathogenic species, is implicated in a wide range of pathologies, including Clostridioides difficile infection, inflammatory bowel disease (IBD), and metabolic syndromes like obesity and type 2 diabetes (Science, 2021). Therapeutic strategies targeting this environment include the use of narrow-spectrum antibiotics, probiotics, prebiotics, and fecal microbiota transplantation (FMT) to restore a healthy microbial balance (Cell, 2020). Unlike traditional molecular targets, the gut microbiota is a multi-species community where drug interactions often involve altering metabolic pathways or ecological competition rather than binding to a single host receptor. Recent advancements have led to the approval of live biotherapeutic products, such as SER-109, which specifically target the luminal environment to prevent recurrent infections (FDA, 2023).

Other names

Gut microbiomeIntestinal floraGastrointestinal microbiotaGut lumenEnteric environment

Modulation of the microbial ecosystem through the introduction of beneficial taxa, suppression of pathogens via competitive exclusion or antimicrobial action, and restoration of metabolic byproducts such as short-chain fatty acids and secondary bile acids (Nature, 2021; PubMed, 2022).